HealthChinese drug sector gains stature at major cancer conference

Chinese drug makers presented positive trial results for new cancer treatments at a major European medical conference, highlighting the biotech sector’s growing international influence. Analysts said innovative domestic drugs, particularly antibody-drug conjugates, showed strong data across several tumour types, with early results also demonstrating China’s innovation capabilities.

Chinese biotechcancer treatmentsclinical trialsantibody-drug conjugates

SSouth China Morning Post★★☆☆☆2026-10-28 10:00Original